Inhibitory Antibodies
抑制性抗体(Inhibitory Antibodies,常被称为中和抗体或阻断抗体)是一种能够特异性结合目标分子(如受体、酶或细胞因子),并直接抑制或阻断其正常生物学功能的特异性抗体。
| 货号 | 产品 | 反应 | 应用 | 偶联 | 引用 |
|---|---|---|---|---|---|
| BF6000 | Tebentafusp | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6001 | Ipafricept | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6002 | Atacicept | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6003 | Baminercept | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6004 | Sotatercept | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6005 | Simlukafusp alfa | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6006 | Latikafusp | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6007 | Nemvaleukin alfa | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6008 | Insulin efsitora alfa | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6009 | Recifercept | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6010 | Ponsegromab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6011 | Depatuxizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6012 | Panobacumab | Pseudomonas aeruginosa | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6013 | Zanolimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6014 | Avelumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6015 | Natalizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6016 | Amatuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6017 | Ipilimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6018 | Pembrolizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6019 | Fresolimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6020 | Magrolimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6021 | Atezolizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6022 | Sacituzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6023 | Cetuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6024 | Urelumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6025 | Zolbetuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6026 | Bevacizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6027 | Trastuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6028 | Adalimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6029 | Obinutuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6030 | Vedolizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6031 | Golimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6032 | Pertuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6033 | Rituximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6034 | Daratumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6035 | Relatlimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6036 | Teprotumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6037 | Durvalumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6038 | Ramucirumab (anti-VEGFR) | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6039 | Zilovertamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6040 | Motavizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6041 | Sifalimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6042 | Benralizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6043 | Pivekimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6044 | Risankizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6045 | Vonlerolizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6046 | Secukinumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6047 | Patritumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6048 | Tesidolumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6049 | Bimagrumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |